A novel LFA-1 activation epitope maps to the I domain - PubMed (original) (raw)

A novel LFA-1 activation epitope maps to the I domain

R C Landis et al. J Cell Biol. 1993 Mar.

Abstract

A panel of 21 alpha-subunit (CD11a) and 10 beta-subunit (CD18) anti-LFA-1 mAbs was screened for ability to activate LFA-1. A single anti-CD11a mAb, MEM-83, was identified which was able to directly induce the binding of T cells to purified ICAM-1 immobilized on plastic. This ICAM-1 binding could be achieved by monovalent Fab fragments of mAb MEM-83 at concentrations equivalent to whole antibody, was associated with appearance of the "activation reporter" epitope detected by mAb 24, and was completely inhibited by anti-ICAM-1 and LFA-1 blocking mAbs. The epitope recognized by mAb MEM-83 was distinct from that recognized by mAb NKI-L16, an anti-CD11a mAb previously reported to induce LFA-1 activation, in that it was constitutively present on freshly isolated peripheral blood mononuclear cells and was not divalent cation dependent for expression. The ICAM-1 binding activity induced by mAb MEM-83 was, however, dependent on the presence of Mg2+ divalent cations. Using an in vitro-translated CD11a cDNA deletion series, we have mapped the MEM-83 activation epitope to the "I" domain of the LFA-1 alpha subunit. These studies have therefore identified a novel LFA-1 activation epitope mapping to the I domain of LFA-1, thereby implicating this domain in the regulation of LFA-1 binding to ICAM-1.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Cell Biol. 1980 Mar;84(3):584-98 - PubMed
    1. Biochem J. 1992 Mar 1;282 ( Pt 2):523-32 - PubMed
    1. J Biol Chem. 1985 Sep 15;260(20):11107-14 - PubMed
    1. Scand J Immunol. 1985 Aug;22(2):171-82 - PubMed
    1. J Exp Med. 1986 May 1;163(5):1132-49 - PubMed

MeSH terms

Substances

LinkOut - more resources